118 related articles for article (PubMed ID: 7493678)
21. Frequency of clonal remission in acute myeloid leukaemia.
Gale RE; Wheadon H; Goldstone AH; Burnett AK; Linch DC
Lancet; 1993 Jan; 341(8838):138-42. PubMed ID: 8093744
[TBL] [Abstract][Full Text] [Related]
22. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome.
Smalberg JH; Darwish Murad S; Braakman E; Valk PJ; Janssen HL; Leebeek FW
Haematologica; 2006 Dec; 91(12):1712-3. PubMed ID: 17145613
[TBL] [Abstract][Full Text] [Related]
23. [Clonal study of hematopoietic cells].
Jinnai I
Rinsho Ketsueki; 1995 Apr; 36(4):273-8. PubMed ID: 7783329
[TBL] [Abstract][Full Text] [Related]
24. Clonality of chronic neutrophilic leukaemia associated with myeloma: analysis using the X-linked probe M27 beta.
Standen GR; Steers FJ; Jones L
J Clin Pathol; 1993 Apr; 46(4):297-8. PubMed ID: 8098719
[TBL] [Abstract][Full Text] [Related]
25. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis.
Primignani M; Barosi G; Bergamaschi G; Gianelli U; Fabris F; Reati R; Dell'Era A; Bucciarelli P; Mannucci PM
Hepatology; 2006 Dec; 44(6):1528-34. PubMed ID: 17133457
[TBL] [Abstract][Full Text] [Related]
26. Carrier detection in Wiskott-Aldrich syndrome: combined use of M27 beta for X-inactivation studies and as a linked probe.
Goodship J; Carter J; Espanol T; Boyd Y; Malcolm S; Levinsky RJ
Blood; 1991 Jun; 77(12):2677-81. PubMed ID: 2043768
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetic approach to the analysis of clonal proliferation in hematologic disorders.
Morita K; Tsukamoto N; Karasawa M; Omine M
Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1414-22. PubMed ID: 2576494
[TBL] [Abstract][Full Text] [Related]
28. Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms.
Tsukamoto N; Morita K; Maehara T; Okamoto K; Karasawa M; Omine M; Naruse T
Br J Haematol; 1993 Apr; 83(4):589-94. PubMed ID: 8100140
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome.
Hirshberg B; Shouval D; Fibach E; Friedman G; Ben-Yehuda D
J Hepatol; 2000 Apr; 32(4):574-8. PubMed ID: 10782905
[TBL] [Abstract][Full Text] [Related]
30. Endogenous erythroid colony formation in patients with retinal vein occlusion.
Héron E; Marzac C; Feldman-Billard S; Girmens JF; Paques M; Delarue R; Piette JC; Casadevall N; Hermine O
Ophthalmology; 2007 Dec; 114(12):2155-61. PubMed ID: 18054634
[TBL] [Abstract][Full Text] [Related]
31. X-chromosome methylation in manifesting and healthy carriers of dystrophinopathies: concordance of activation ratios among first degree female relatives and skewed inactivation as cause of the affected phenotypes.
Azofeifa J; Voit T; Hübner C; Cremer M
Hum Genet; 1995 Aug; 96(2):167-76. PubMed ID: 7635465
[TBL] [Abstract][Full Text] [Related]
32. Clonal composition of human adrenocortical neoplasms.
Beuschlein F; Reincke M; Karl M; Travis WD; Jaursch-Hancke C; Abdelhamid S; Chrousos GP; Allolio B
Cancer Res; 1994 Sep; 54(18):4927-32. PubMed ID: 7915195
[TBL] [Abstract][Full Text] [Related]
33. Neither uniparental disomy nor skewed X-inactivation explains Rett syndrome.
Webb T; Watkiss E; Woods CG
Clin Genet; 1993 Nov; 44(5):236-40. PubMed ID: 7906210
[TBL] [Abstract][Full Text] [Related]
34. Clonality in hematopoietic disorders.
Hotta T
Int J Hematol; 1997 Dec; 66(4):403-12. PubMed ID: 9479867
[TBL] [Abstract][Full Text] [Related]
35. [Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F].
Fama A; Rago A; Gioiosa F; Marzano C; Latagliata R; Mammì C; Laganà C; D'Elia GM; Bizzoni L; Trasarti S; Ferretti A; Breccia M; Riggio O; Tafuri A
Clin Ter; 2010; 161(2):169-71. PubMed ID: 20499034
[TBL] [Abstract][Full Text] [Related]
36. Polycythemia and the Budd-Chiari syndrome: study of serum erythropoietin and bone marrow erythroid progenitors.
Levy VG; Ruskone A; Baillou C; Theirman-Duffaud D; Najman A; Boffa GA
Hepatology; 1985; 5(5):858-61. PubMed ID: 4029896
[TBL] [Abstract][Full Text] [Related]
37. Analysis of meningiomas by methylation- and transcription-based clonality assays.
Zhu J; Frosch MP; Busque L; Beggs AH; Dashner K; Gilliland DG; Black PM
Cancer Res; 1995 Sep; 55(17):3865-72. PubMed ID: 7641206
[TBL] [Abstract][Full Text] [Related]
38. [Budd-Chiari syndrome associated with chronic myeloproliferative syndromes: analysis of 6 cases].
Cobo F; Cervantes F; García-Pagán JC; Bosch J; Rozman C; Montserrat E
Med Clin (Barc); 1996 Nov; 107(17):660-3. PubMed ID: 9064408
[TBL] [Abstract][Full Text] [Related]
39. Clonality of cell populations in refractory anaemia using combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analyses.
Abrahamson G; Boultwood J; Madden J; Kelly S; Oscier DG; Rack K; Buckle VJ; Wainscoat JS
Br J Haematol; 1991 Dec; 79(4):550-5. PubMed ID: 1685326
[TBL] [Abstract][Full Text] [Related]
40. X inactivation as a mechanism of selection against lethal alleles: further investigation of incontinentia pigmenti and X linked lymphoproliferative disease.
Harris A; Collins J; Vetrie D; Cole C; Bobrow M
J Med Genet; 1992 Sep; 29(9):608-14. PubMed ID: 1404291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]